custom search
Reversed
Tech Center 1600 Biotechnology and Organic Chemistry
1644 John D. Lambris et al. 12918101 GRIMES 112(1)/103 POTTER ANDERSON & CORROON LLP GAMBEL, PHILLIP
1649 Jae Gyun. Jeong 15030999 PRATS 112(1) FENWICK & WEST LLP ULM, JOHN D
1743 David J. Cooper 13934256 MCGEE 103 Guardian Glass, LLC c/o KCPS IP Dept./Shannon Gonsalves ROBITAILLE, JOHN P
1792 Tobias Richter 14278695 GAUDETTE 103 Brooks Kushman BECKER, DREW E
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2465 Wanshi Chen et al. 14264220 CUTITTA 102/103 Patterson & Sheridan, L.L.P. Qualcomm DIVITO, WALTER J
2621 Imran A. Chaudhri et al. 14142640 PER CURIAM 103 DENTONS US LLP - Apple BRAY, STEPHEN A
2655 Oskar Myhre. Broberg et al. 14660275 CUTITTA 102/103 SUGHRUE MION, PLLC DABNEY, PHYLESHA LARVINIA
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2837 Noboru Shiokawa 14996561 BEST 103 Studebaker & Brackett PC BARNES, MALCOLM
2883 Michael David. Simmonds et al. 13265260 MANTIS MERCADER 103 SCULLY SCOTT MURPHY & PRESSER, PC RADKOWSKI, PETER
2886 Herbert Gross et al. 15100244 GAUDETTE 103 SLATER MATSIL, LLP AKANBI, ISIAKA O
Our reviewing court, however, has explained that “dictionary definitions must give way to the meaning imparted by the specification.” In re Johnston, 435 F.3d 1381, 1384 (Fed. Cir. 2006). “Even when guidance is not provided in explicit definitional format, the specification may define claim terms by implication such that the meaning may be found in or ascertained by a reading of the patent documents.” Irdeto Access, Inc. v. Echostar Satellite Corp., 383 F.3d 1295, 1300 (Fed. Cir. 2004) (internal quotation marks omitted), quoted in In re Abbott Diabetes Care Inc., 696 F.3d 1142, 1150 (Fed. Cir. 2012).
Abbott Diabetes Care Inc., In re, 696 F.3d 1142, 104 USPQ2d 1337 (Fed. Cir. 2012) 2111.01
3695 Michael Gooch et al. 11011883 ENGLE 112(1)/101 CANTOR FITZGERALD, L.P. POLLOCK, GREGORY A
3763 Bruce Mccormick 13333457 PLENZLER 103 41.50 112(2) JAMES D. STEVENS REISING ETHINGTON P.C. FEBLES, ANTONIO R
Affirmed-in-Part
1721 Andreas Pawlik et al. 13649498 RANGE 103 103 OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. MARTIN, BETHANY LAMBRIGHT
Affirmed
Tech Center 1600 Biotechnology and Organic Chemistry
1612 Weiguang Wang 13991608 ADAMS 103 PATTERSON THUENTE PEDERSEN, P.A. KISHORE, GOLLAMUDI S
1613 Christopher Michael. Macneill et al. 14979313 FLAX 103 OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. BASQUILL, SEAN M
1627 Rathmacher, John et al. 12973803 HARDMAN 103 102/103 Davis Brown Law Firm/ Metabolic Technologies, Inc. CHONG, YONG SOO
1649 Catherine Rougeot 14730396 FLAX OTDP ARRIGO, LEE, GUTTMAN & MOUTA-BELLUM LLP CHERNYSHEV, OLGA N
Tech Center 1700 Chemical & Materials Engineering
1714 Leandro P. Rizzuto et al. 13551007 KENNEDY 103 Conair Corporation Grogan, Tuccillo & Vanderleeden, LLP WHATLEY, KATELYN B
1783 Ake Sjoberg 13595795 INGLESE 103 Pergo LLC Jenkins, Wilson, Taylor & Hunt, P.A. VAN SELL, NATHAN L
Tech Center 2600 Communications
2626 Philip Lawrence 13714172 NAPPI 103 NVIDIA C/O MURABITO, HAO & BARNES LLP CRAWLEY, KEITH L
2658 Venkata V. Gadepalli et al. 15257109 KUMAR 101/103 IBM CORPORATION - ENDICOTT (JVL) C/O LESLIE A. VAN LEEUWEN SAINT CYR, LEONARD
2691 Hatambeiki, Arsham et al. 12645037 MORGAN 103 Greenberg Traurig, LLP TRUONG, NGUYEN H
2872 Fetze Pijlman et al. 15233084 INGLESE 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS CHANG, AUDREY Y
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3623 Rodrigo Pierzchalski. Carvalho 13841136 KUMAR 101/103 Greenberg Traurig, LLP GILLS, KURTIS
3623 John Edward. O'Malley et al. 13111804 McCARTNEY 103 FIS/FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP ROSS, SCOTT M
3624 Richard Tyler. Curtis et al. 13464314 AMUNDSON 101 Kraguljac Law Group/Oracle BEHNCKE, CHRISTINE M
3625 Deborah Liu 14196227 McCARTNEY 103 101 Facebook/Fenwick PALAVECINO, KATHLEEN GAGE
3681 Marc Rowen 10426498 CALVE 101/103 Invoke / Oracle BUSCH, CHRISTOPHER CONRAD
3682 Andrew G. Bosworth et al. 13611522 MEDLOCK 101 Facebook/Fenwick SITTNER, MATTHEW T
3683 Juan J. Liu et al. 13797663 KUMAR 101 PVF -- PARC c/o PARK, VAUGHAN, FLEMING & DOWLER LLP MEINECKE DIAZ, SUSANNA M
3684 Liang Gou et al. 14453081 AMUNDSON 101 IBM CORP. (WIP) c/o WALDER INTELLECTUAL PROPERTY LAW, P.C. ZIMMERMAN, MATTHEW E
3694 Rosenthal, Brian 13954913 ARPIN 101 Facebook/Fenwick ANDERSON, SCOTT C
3696 Lutnick, Howard W. et al. 13887486 MEYERS 101/103/OTDP INNOVATION DIVISION CANTOR FITZGERALD, L.P. HOLLY, JOHN H
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3715 Sloan, J. Nathaniel. et al. 14757978 CAPP 101 DISNEY ENTERPRISES, INC. c/o Fay Kaplun & Marcin, LLP LIM, SENG HENG
3715 Solheim Witt, Marit 13760715 PLENZLER 101 ALLISON JOHNSON, P.A. BULLINGTON, ROBERT P
SEARCH
PTAB.US: Decisions of PTAB Patent Trial and Appeal Board
Li & Cai
Showing posts with label abbott diabetes. Show all posts
Showing posts with label abbott diabetes. Show all posts
Friday, December 20, 2019
Wednesday, January 18, 2017
abbott diabetes, irdeto
custom search
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1791 Ex Parte Duan et al 13007610 - (D) SMITH 103 DAVIS, BROWN, KOEHN, SHORS & ROBERTS, P.C. SAYALA, CHHAYA D
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2449 Ex Parte ZHANG 13435704 - (D) EVANS 103 Cuenot, Forsythe & Kim, LLC BUKHARI, SIBTE H
Thus, Appellant has defined “client type” to be software, at least by implication. “Even when guidance is not provided in explicit definitional format, the specification may define claim terms by implication such that the meaning may be found in or ascertained by a reading of the patent documents.” In Re Abbott Diabetes Care Inc., 696 F.3d 1142, 1150 (Fed. Cir. 2012) (quoting Irdeto Access, Inc. v. EchoStar Satellite Corp., 383 F.3d 1295, 1300 (Fed. Cir. 2004)).
Abbott Diabetes Care Inc., In re, 696 F.3d 1142, 104 USPQ2d 1337 (Fed. Cir. 2012) 2111.01
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3696 Ex Parte Marsan et al 13560555 - (D) MEYERS 103 Jackson Walker LLP TROTTER, SCOTT S
AFFIRMED-IN-PART
Tech Center 1700 Chemical & Materials Engineering
1764 Ex Parte Funk et al 13266181 - (D) ROSS 103 103 MARSHALL, GERSTEIN & BORUN LLP KAUCHER, MARK S
Tech Center 2100 Computer Architecture and Software
2191 Ex Parte Pendergrass et al 13559255 - (D) HOMERE 112(1)/112(2)/103 103 Hewlett Packard Enterprise LYONS, ANDREW M
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3766 Ex Parte Libbus et al 13867778 - (D) PESLAK 103 103 41.50 103 SCHWEGMAN LUNDBERG & WOESSNER/BSC PATEL, NATASHA
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1616 Ex Parte Martin 13899000 - (D) CHANG 103 Baker Donelson Bearman, Caldwell & Berkowitz, PC BRANSON, DANIEL L
Tech Center 1700 Chemical & Materials Engineering
1767 Ex Parte BROTHERS et al 13965317 - (D) GUPTA 103 The Chemours Company BUIE-HATCHER, NICOLE M
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2473 Ex Parte Gonikberg et al 13621899 - (D) HOWARD 103 GARLICK & MARKISON (BRCM) PATEL, HARDIKKUMAR D
Tech Center 2600 Communications
2625 Ex Parte Grant et al 11943862 - (D) CUTITTA 103 Kilpatrick Townsend and Stockton, LLP PARKER, JEFFREY ALAN
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3622 Ex Parte Sim et al 13447099 - (D) MEDLOCK 102/103 101/112(2) Facebook/Fenwiok SITTNER, MICHAEL J
3688 Ex Parte SLUTSKY et al 13248937 - (D) MEDLOCK 103 QUALCOMM INCORPORATED PATEL, DIPEN M
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1791 Ex Parte Duan et al 13007610 - (D) SMITH 103 DAVIS, BROWN, KOEHN, SHORS & ROBERTS, P.C. SAYALA, CHHAYA D
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2449 Ex Parte ZHANG 13435704 - (D) EVANS 103 Cuenot, Forsythe & Kim, LLC BUKHARI, SIBTE H
Thus, Appellant has defined “client type” to be software, at least by implication. “Even when guidance is not provided in explicit definitional format, the specification may define claim terms by implication such that the meaning may be found in or ascertained by a reading of the patent documents.” In Re Abbott Diabetes Care Inc., 696 F.3d 1142, 1150 (Fed. Cir. 2012) (quoting Irdeto Access, Inc. v. EchoStar Satellite Corp., 383 F.3d 1295, 1300 (Fed. Cir. 2004)).
Abbott Diabetes Care Inc., In re, 696 F.3d 1142, 104 USPQ2d 1337 (Fed. Cir. 2012) 2111.01
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3696 Ex Parte Marsan et al 13560555 - (D) MEYERS 103 Jackson Walker LLP TROTTER, SCOTT S
AFFIRMED-IN-PART
Tech Center 1700 Chemical & Materials Engineering
1764 Ex Parte Funk et al 13266181 - (D) ROSS 103 103 MARSHALL, GERSTEIN & BORUN LLP KAUCHER, MARK S
Tech Center 2100 Computer Architecture and Software
2191 Ex Parte Pendergrass et al 13559255 - (D) HOMERE 112(1)/112(2)/103 103 Hewlett Packard Enterprise LYONS, ANDREW M
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3766 Ex Parte Libbus et al 13867778 - (D) PESLAK 103 103 41.50 103 SCHWEGMAN LUNDBERG & WOESSNER/BSC PATEL, NATASHA
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1616 Ex Parte Martin 13899000 - (D) CHANG 103 Baker Donelson Bearman, Caldwell & Berkowitz, PC BRANSON, DANIEL L
Tech Center 1700 Chemical & Materials Engineering
1767 Ex Parte BROTHERS et al 13965317 - (D) GUPTA 103 The Chemours Company BUIE-HATCHER, NICOLE M
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2473 Ex Parte Gonikberg et al 13621899 - (D) HOWARD 103 GARLICK & MARKISON (BRCM) PATEL, HARDIKKUMAR D
Tech Center 2600 Communications
2625 Ex Parte Grant et al 11943862 - (D) CUTITTA 103 Kilpatrick Townsend and Stockton, LLP PARKER, JEFFREY ALAN
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3622 Ex Parte Sim et al 13447099 - (D) MEDLOCK 102/103 101/112(2) Facebook/Fenwiok SITTNER, MICHAEL J
3688 Ex Parte SLUTSKY et al 13248937 - (D) MEDLOCK 103 QUALCOMM INCORPORATED PATEL, DIPEN M
Labels:
abbott diabetes
,
irdeto
Wednesday, February 24, 2016
abbott diabetes, suitco surface
custom search
REVERSED
Tech Center 2100 Computer Architecture and Software
2155 Ex Parte Mitchell et al 12757112 - (D) MARGOLIES 102/103 Hewlett Packard Enterprise HERSHLEY, MARK E
2197 Ex Parte Sobel 11860060 - (D) WORMMEESTER 103 WILMERHALE BODDEN, EVRAL E
Tech Center 2600 Communications
2669 Ex Parte He et al 11271693 - (D) MARGOLIES 103 NXP-TERRILE, CANNATTI, CHAMBERS & HOLLAND - FSL ROZ, MARK
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3725 Ex Parte Bindra 12283769 - (D) CALVE 102/103 Harding, Earley, Follmer & Frailey LEWIS, JUSTIN V
3745 Ex Parte Tholen et al 11755281 - (D) HOFFMANN 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY VERDIER, CHRISTOPHER M
3762 Ex Parte Gerber 11591171 - (D) MAYBERRY 102/103 SHUMAKER & SIEFFERT , P.A LEVICKY, WILLIAM J
We are instructed that "claims under examination before the [U.S. Patent and Trademark Office] are given their broadest reasonable interpretation consistent with the specification." In re Abbott Diabetes Care Inc., 696 F.3d 1142, 1148 (Fed. Cir. 2012) (citation omitted). However, [t]he broadest-construction rubric . . . does not give the [Examiner] an unfettered license to interpret claims to embrace anything remotely related to the claimed invention." In re Suitco Surface, Inc., 603 F.3d 1255, 1260 (Fed. Cir. 2010).
Abbott Diabetes Care Inc., In re, 696 F.3d 1142, 104 USPQ2d 1337 (Fed. Cir. 2012) 2111.01
Suitco Surface, Inc., In re, 603 F.3d 1255, 1260 (Fed. Cir. 2010) 2111 , 2111.01
AFFIRMED-IN-PART
Tech Center 2100 Computer Architecture and Software
2173 Ex Parte NG et al 12702371 - (D) HOMERE 103 103 KENYON & KENYON LLP SHIH, HAOSHIAN
AFFIRMED
Tech Center 2100 Computer Architecture and Software
2159 Ex Parte Schmidt 12833598 - (D) KUMAR 102/103 Ditthavong & Steiner, P.C. BURKE, JEFF A
Tech Center 2600 Communications
2672 Ex Parte Bouchard et al 12271571 - (D) PYONIN 102/103 BAKER & HOSTETLER LLP VO, QUANG N
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3652 Ex Parte Laese 12675948 - (D) GREENHUT 103 HAYES SOLOWAY P.C. VU, STEPHEN A
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Wilk 11387522 - (D) ABRAMS 112(1) Cosud Intellectual Property Solutions, P.C. BACHMAN, LINDSEY MICHELE
REVERSED
Tech Center 2100 Computer Architecture and Software
2155 Ex Parte Mitchell et al 12757112 - (D) MARGOLIES 102/103 Hewlett Packard Enterprise HERSHLEY, MARK E
2197 Ex Parte Sobel 11860060 - (D) WORMMEESTER 103 WILMERHALE BODDEN, EVRAL E
Tech Center 2600 Communications
2669 Ex Parte He et al 11271693 - (D) MARGOLIES 103 NXP-TERRILE, CANNATTI, CHAMBERS & HOLLAND - FSL ROZ, MARK
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3725 Ex Parte Bindra 12283769 - (D) CALVE 102/103 Harding, Earley, Follmer & Frailey LEWIS, JUSTIN V
3745 Ex Parte Tholen et al 11755281 - (D) HOFFMANN 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY VERDIER, CHRISTOPHER M
3762 Ex Parte Gerber 11591171 - (D) MAYBERRY 102/103 SHUMAKER & SIEFFERT , P.A LEVICKY, WILLIAM J
We are instructed that "claims under examination before the [U.S. Patent and Trademark Office] are given their broadest reasonable interpretation consistent with the specification." In re Abbott Diabetes Care Inc., 696 F.3d 1142, 1148 (Fed. Cir. 2012) (citation omitted). However, [t]he broadest-construction rubric . . . does not give the [Examiner] an unfettered license to interpret claims to embrace anything remotely related to the claimed invention." In re Suitco Surface, Inc., 603 F.3d 1255, 1260 (Fed. Cir. 2010).
Abbott Diabetes Care Inc., In re, 696 F.3d 1142, 104 USPQ2d 1337 (Fed. Cir. 2012) 2111.01
Suitco Surface, Inc., In re, 603 F.3d 1255, 1260 (Fed. Cir. 2010) 2111 , 2111.01
AFFIRMED-IN-PART
Tech Center 2100 Computer Architecture and Software
2173 Ex Parte NG et al 12702371 - (D) HOMERE 103 103 KENYON & KENYON LLP SHIH, HAOSHIAN
AFFIRMED
Tech Center 2100 Computer Architecture and Software
2159 Ex Parte Schmidt 12833598 - (D) KUMAR 102/103 Ditthavong & Steiner, P.C. BURKE, JEFF A
Tech Center 2600 Communications
2672 Ex Parte Bouchard et al 12271571 - (D) PYONIN 102/103 BAKER & HOSTETLER LLP VO, QUANG N
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3652 Ex Parte Laese 12675948 - (D) GREENHUT 103 HAYES SOLOWAY P.C. VU, STEPHEN A
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Wilk 11387522 - (D) ABRAMS 112(1) Cosud Intellectual Property Solutions, P.C. BACHMAN, LINDSEY MICHELE
Labels:
abbott diabetes
,
suitco surface
Tuesday, February 10, 2015
exxon chem, teva2, markman, abbott diabetes
custom search
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1793 Ex Parte Zoltai et al 13450073 - (D) TIMM 112(1)/102 37 C.F.R. § 41.50(b) 112(2) FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP WONG, LESLIE A
The Examiner and this Board have an independent obligation to determine the meaning of an application’s claims, notwithstanding the views asserted by an applicant. The obligation is analogous to that of district and appeals court judges. See, e.g., Exxon Chem. Patents, Inc. v. Lubrizol Corp., 64 F.3d 1553, 1555 (Fed. Cir. 1995) (“the trial judge has an independent obligation to determine the meaning of the claims, notwithstanding the views asserted by the adversary parties.”); see also Teva Pharm. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 835 (2015) (quoting Markman v. Westview Instruments, Inc., 517 U.S. 370, (1996) (“‘the construction of a patent, including terms of art within its claim,’ is not for a jury but ‘exclusively’ for ‘the court’ to determine.”); In re Abbott Diabetes Care Inc., 696 F.3d 1142, 1148 (Fed. Cir. 2012) (Although, “[i]n contrast to district court proceedings involving an issued patent, claims under examination before the PTO are given their broadest reasonable interpretation consistent with the specification,” claim construction remains a legal question, reviewed de novo.).
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3651 Ex Parte Pearl et al 12145954 - (D) MAYBERRY 103 37 C.F.R. § 41.50(b) 102 BOYLE FREDRICKSON S.C. KUMAR, RAKESH
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3788 Ex Parte Henke et al 12375556 - (D) CALVE 103/ obviousness-type double patenting MILLEN, WHITE, ZELANO & BRANIGAN, P.C. CHU, KING M
AFFIRMED-IN-PART
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2486 Ex Parte Murray et al 10555214 - (D) HOMERE 102/103 102/103 Husch Blackwell LLP Husch Blackwell Sanders LLP Welsh & Katz VO, TUNG T
2492 Ex Parte Karnik 12195737 - (D) HUME 102 102/103 MILLER IP GROUP, PLC GENERAL MOTORS CORPORATION PAN, PEILIANG
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3617 Ex Parte SMITH et al 12368284 - (D) STAICOVICI 103 103 37 C.F.R. § 41.50(b) 103 GE GPO- Transportation- The Small Patent Law Group LE, MARK T
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1741 Ex Parte YIN et al 13163088 - (D) ANKENBRAND 103 INTERNATIONAL PAPER COMPANY CALANDRA, ANTHONY J
1791 Ex Parte Jendrysik et al 12766998 - (D) ROESEL 103 BANNER & WITCOFF, LTD. GWARTNEY, ELIZABETH A
Tech Center 2600 Communications
2686 Ex Parte Giorgi et al 12059539 - (D) FRAHM 102/103 ZILKA-KOTAB, PC- HIT KLIMOWICZ, WILLIAM JOSEPH
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2891 Ex Parte Gillies et al 11175196 - (D) HANLON 112(2) HOFFMAN WARNICK LLC TORNOW, MARK W
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3711 Ex Parte Lampert et al 11983403 - (D) GUIJT 103 DOCKET CLERK STANCZAK, MATTHEW BRIAN
REEXAMINATION
AFFIRMED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3744 TAIWAN MICROLOOPS CORPORATION and HEWLETT PACKARD COMPANY Requester, Cross-Appellant, Respondent v. CONVERGENCE TECHNOLOGIES (USA) Patent Owner, Appellant, Respondent Ex Parte 7422053 et al 11/272,145 95001749 - (D) SONG 103 EDELL, SHAPIRO & FINNAN, LLC THIRD PARTY REQUESTER: PATTERSON THUENTE CHRISTENSEN PEDERSEN, P.A. CLARKE, SARA SACHIE original FLANIGAN, ALLEN J
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1793 Ex Parte Zoltai et al 13450073 - (D) TIMM 112(1)/102 37 C.F.R. § 41.50(b) 112(2) FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP WONG, LESLIE A
The Examiner and this Board have an independent obligation to determine the meaning of an application’s claims, notwithstanding the views asserted by an applicant. The obligation is analogous to that of district and appeals court judges. See, e.g., Exxon Chem. Patents, Inc. v. Lubrizol Corp., 64 F.3d 1553, 1555 (Fed. Cir. 1995) (“the trial judge has an independent obligation to determine the meaning of the claims, notwithstanding the views asserted by the adversary parties.”); see also Teva Pharm. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 835 (2015) (quoting Markman v. Westview Instruments, Inc., 517 U.S. 370, (1996) (“‘the construction of a patent, including terms of art within its claim,’ is not for a jury but ‘exclusively’ for ‘the court’ to determine.”); In re Abbott Diabetes Care Inc., 696 F.3d 1142, 1148 (Fed. Cir. 2012) (Although, “[i]n contrast to district court proceedings involving an issued patent, claims under examination before the PTO are given their broadest reasonable interpretation consistent with the specification,” claim construction remains a legal question, reviewed de novo.).
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3651 Ex Parte Pearl et al 12145954 - (D) MAYBERRY 103 37 C.F.R. § 41.50(b) 102 BOYLE FREDRICKSON S.C. KUMAR, RAKESH
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3788 Ex Parte Henke et al 12375556 - (D) CALVE 103/ obviousness-type double patenting MILLEN, WHITE, ZELANO & BRANIGAN, P.C. CHU, KING M
AFFIRMED-IN-PART
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2486 Ex Parte Murray et al 10555214 - (D) HOMERE 102/103 102/103 Husch Blackwell LLP Husch Blackwell Sanders LLP Welsh & Katz VO, TUNG T
2492 Ex Parte Karnik 12195737 - (D) HUME 102 102/103 MILLER IP GROUP, PLC GENERAL MOTORS CORPORATION PAN, PEILIANG
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3617 Ex Parte SMITH et al 12368284 - (D) STAICOVICI 103 103 37 C.F.R. § 41.50(b) 103 GE GPO- Transportation- The Small Patent Law Group LE, MARK T
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1741 Ex Parte YIN et al 13163088 - (D) ANKENBRAND 103 INTERNATIONAL PAPER COMPANY CALANDRA, ANTHONY J
1791 Ex Parte Jendrysik et al 12766998 - (D) ROESEL 103 BANNER & WITCOFF, LTD. GWARTNEY, ELIZABETH A
Tech Center 2600 Communications
2686 Ex Parte Giorgi et al 12059539 - (D) FRAHM 102/103 ZILKA-KOTAB, PC- HIT KLIMOWICZ, WILLIAM JOSEPH
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2891 Ex Parte Gillies et al 11175196 - (D) HANLON 112(2) HOFFMAN WARNICK LLC TORNOW, MARK W
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3711 Ex Parte Lampert et al 11983403 - (D) GUIJT 103 DOCKET CLERK STANCZAK, MATTHEW BRIAN
REEXAMINATION
AFFIRMED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3744 TAIWAN MICROLOOPS CORPORATION and HEWLETT PACKARD COMPANY Requester, Cross-Appellant, Respondent v. CONVERGENCE TECHNOLOGIES (USA) Patent Owner, Appellant, Respondent Ex Parte 7422053 et al 11/272,145 95001749 - (D) SONG 103 EDELL, SHAPIRO & FINNAN, LLC THIRD PARTY REQUESTER: PATTERSON THUENTE CHRISTENSEN PEDERSEN, P.A. CLARKE, SARA SACHIE original FLANIGAN, ALLEN J
Labels:
abbott diabetes
,
exxon chem
,
markman
,
teva2
Thursday, June 5, 2014
rambus, abbott diabetes
custom search
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1729 Ex Parte HOCHGRAF et al 12187069 - (D) NAGUMO 102 GENERAL MOTORS CORPORATION MILLER IP GROUP, PLC WANG, EUGENIA
Tech Center 2100 Computer Architecture and Software
2158 Ex Parte Ramer et al 11553713 - (D) LORIN 102 Millennial Media, Inc. TRAN, BAO G
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3687 Ex Parte Canter et al 11772533 - (D) FETTING 102/103 DOCKET CLERK AN, IG TAI
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1789 Ex Parte Wright 11564786 - (D) PER CURIAM 103 Ballard Spahr LLP JUSKA, CHERYL ANN
1789 Ex Parte Wright 11564771 - (D) PER CURIAM 103 Ballard Spahr LLP JUSKA, CHERYL ANN
Tech Center 2100 Computer Architecture and Software
2172 Ex Parte OSullivan et al 11948458 - (D) PAULRAJ 102/103 CRGO LAW STEVEN M. GREENBERG TAN, ALVIN H
In applying a broadest reasonable interpretation standard, the Federal Circuit had recognized that a statement in a specification that a claim term "refers to" something can serve as a limitation. See In re Rambus, 694 F.3d 42, 45-47 (Fed. Cir. 2012) (construing term "memory device" based on specification's disclosure that "[i]n general, each teaching of this invention which refers to a memory device can be practiced using a tranceiver device and one or more memory devices"); see also In re Abbott Diabetes Care Inc., 696 F.3d 1142, 1150 (Fed. Cir. 2012) (recognizing that "[e]ven when guidance is not provided in a explicit definitional format, the specification may define claim terms by implication such that the meaning may be found in or ascertained by a reading of the patent documents").
2172 Ex Parte OSullivan et al 11948438 - (D) PAULRAJ 102/103 CRGO LAW STEVEN M. GREENBERG TAN, ALVIN H
2174 Ex Parte Adachi et al 11970395 - (D) CHERRY 102 101/obviousness-type double patenting CRGO LAW STEVEN M. GREENBERG SHIAU, SHEN C
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2424 Ex Parte Cloonan 10423501 - (D) HUME 103 ARRIS ANDRAMUNO, FRANKLIN S
2443 Ex Parte Bailey et al 11459694 - (D) MEDLOCK 103 IBM CORPORATION BELANI, KISHIN G
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2800 Ex Parte Oowatari et al 12230742 - (D) DELMENDO 103 OLIFF PLC TAMAI, KARL I
2815 Ex Parte Tran 11211911 - (D) PRAISS 103 Wells St. John P.S. LIN, JOHN
2845 Ex Parte Harel et al 12266234 - (D) GARRIS Dissenting WARREN 103 FAY SHARPE/LUCENT LE, HOANGANH T
2898 Ex Parte Daubenspeck et al 12344711 - (D) HANLON 102/103 ROBERTS MLOTKOWSKI SAFRAN & COLE, P.C. SHOOK, DANIEL P
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3663 Ex Parte Breed et al 12020684 - (D) CAPP 103 112(2) 37 C.F.R. § 41.50(b) 112(2) BRIAN ROFFE, ESQ TISSOT, ADAM D
3693 Ex Parte Mahaney et al 10774058 - (D) FETTING 103 BAKER BOTTS L.L.P. NORMAN, SAMICA L
REEXAMINATION
AFFIRMED-IN-PART
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3671 LAWN SOLUTIONS COMMERCIAL PRODUCTS, INC. Requester, Cross-Appellant and Respondent v. TURFCO MANUFACTURING., INC. Patent Owner, Appellant and Respondent Ex Parte 6708773 et al 10/293,528 95001490 - (D) McCARTHY 102/103 102/103 KAMRATH IP Lawfirm, P.A. THIRD-PARTY REQUESTER: Middleton & Reutlinger GRAHAM, MATTHEW C original PEZZUTO, ROBERT ERIC
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1729 Ex Parte HOCHGRAF et al 12187069 - (D) NAGUMO 102 GENERAL MOTORS CORPORATION MILLER IP GROUP, PLC WANG, EUGENIA
Tech Center 2100 Computer Architecture and Software
2158 Ex Parte Ramer et al 11553713 - (D) LORIN 102 Millennial Media, Inc. TRAN, BAO G
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3687 Ex Parte Canter et al 11772533 - (D) FETTING 102/103 DOCKET CLERK AN, IG TAI
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1789 Ex Parte Wright 11564786 - (D) PER CURIAM 103 Ballard Spahr LLP JUSKA, CHERYL ANN
1789 Ex Parte Wright 11564771 - (D) PER CURIAM 103 Ballard Spahr LLP JUSKA, CHERYL ANN
Tech Center 2100 Computer Architecture and Software
2172 Ex Parte OSullivan et al 11948458 - (D) PAULRAJ 102/103 CRGO LAW STEVEN M. GREENBERG TAN, ALVIN H
In applying a broadest reasonable interpretation standard, the Federal Circuit had recognized that a statement in a specification that a claim term "refers to" something can serve as a limitation. See In re Rambus, 694 F.3d 42, 45-47 (Fed. Cir. 2012) (construing term "memory device" based on specification's disclosure that "[i]n general, each teaching of this invention which refers to a memory device can be practiced using a tranceiver device and one or more memory devices"); see also In re Abbott Diabetes Care Inc., 696 F.3d 1142, 1150 (Fed. Cir. 2012) (recognizing that "[e]ven when guidance is not provided in a explicit definitional format, the specification may define claim terms by implication such that the meaning may be found in or ascertained by a reading of the patent documents").
2172 Ex Parte OSullivan et al 11948438 - (D) PAULRAJ 102/103 CRGO LAW STEVEN M. GREENBERG TAN, ALVIN H
2174 Ex Parte Adachi et al 11970395 - (D) CHERRY 102 101/obviousness-type double patenting CRGO LAW STEVEN M. GREENBERG SHIAU, SHEN C
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2424 Ex Parte Cloonan 10423501 - (D) HUME 103 ARRIS ANDRAMUNO, FRANKLIN S
2443 Ex Parte Bailey et al 11459694 - (D) MEDLOCK 103 IBM CORPORATION BELANI, KISHIN G
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2800 Ex Parte Oowatari et al 12230742 - (D) DELMENDO 103 OLIFF PLC TAMAI, KARL I
2815 Ex Parte Tran 11211911 - (D) PRAISS 103 Wells St. John P.S. LIN, JOHN
2845 Ex Parte Harel et al 12266234 - (D) GARRIS Dissenting WARREN 103 FAY SHARPE/LUCENT LE, HOANGANH T
2898 Ex Parte Daubenspeck et al 12344711 - (D) HANLON 102/103 ROBERTS MLOTKOWSKI SAFRAN & COLE, P.C. SHOOK, DANIEL P
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3663 Ex Parte Breed et al 12020684 - (D) CAPP 103 112(2) 37 C.F.R. § 41.50(b) 112(2) BRIAN ROFFE, ESQ TISSOT, ADAM D
3693 Ex Parte Mahaney et al 10774058 - (D) FETTING 103 BAKER BOTTS L.L.P. NORMAN, SAMICA L
REEXAMINATION
AFFIRMED-IN-PART
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3671 LAWN SOLUTIONS COMMERCIAL PRODUCTS, INC. Requester, Cross-Appellant and Respondent v. TURFCO MANUFACTURING., INC. Patent Owner, Appellant and Respondent Ex Parte 6708773 et al 10/293,528 95001490 - (D) McCARTHY 102/103 102/103 KAMRATH IP Lawfirm, P.A. THIRD-PARTY REQUESTER: Middleton & Reutlinger GRAHAM, MATTHEW C original PEZZUTO, ROBERT ERIC
Labels:
abbott diabetes
,
rambus
Subscribe to:
Posts
(
Atom
)